In a previous study, Korean patients with inflammatory demyelinating CNS diseases (including MS patients) were tested for AQP4‐Ab, and 106 (out of 388) were found to be positive (Kim, Kim, Li, Jung, & Kim, 2012). Here, AQP4 is linked to myeloid sarcoma.